Biotech · Private company
Enveda Therapeutics
Track this companyFree. Adds Enveda Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ENV-294Phase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- ENV-294Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- ENV-294Phase 2 · Atopic Dermatitis (AD)ClinicalTrials.gov · fetched Nov 12, 2026
- ENV-294 CapsulePhase 1 · Atopic Dermatitis (AD)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · RECRUITING · started Jun 29, 2026ClinicalTrials.gov NCT07643766 · fetched Nov 12, 2026
- ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in AdultsPHASE2 · RECRUITING · started Jan 9, 2026ClinicalTrials.gov NCT07301255 · fetched Nov 12, 2026
- Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisPHASE2 · RECRUITING · started Dec 22, 2025ClinicalTrials.gov NCT07298395 · fetched Nov 12, 2026
- Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic DermatitisPHASE1 · COMPLETED · started Sep 10, 2025ClinicalTrials.gov NCT07336940 · fetched Nov 12, 2026